survodutide vs semaglutide Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research New Developments in Pharmacological Treatment
Description
While GLP-1R expression in the GI tract is classically ascribed to the myenteric plexus, the highest level of GLP-1R expression in the gut is in the Brunner's glands in the upper duodenum (73, 87)
Overall, 92.3% of participants (n = 312) had a week 68 body weight assessment
Alex Miras, professor of endocrinology at Ulster University in Belfast, Northern Ireland, said he would support the use of the medication in adolescents, provided they were monitored by a multidisciplinary team
Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation
The drugs active ingredient, semaglutide, is a synthetic version of the GLP-1 (glucagon-like peptide-1) hormone, which the body naturally produces after eating
